Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 18, 2011 - Issue 4
Submit an article Journal homepage
371
Views
22
CrossRef citations to date
0
Altmetric
Case Reports

Successful use of Tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis

César Magro-ChecaDepartment of Rheumatology, Hospital Universitario San Cecilio, Granada, SpainCorrespondence[email protected]
,
Antonio Navas-Parejo CasadoDepartment of Nephrology, Hospital Universitario San Cecilio, Granada, Spain
,
Elena Borrego-GarcíaDepartment of Nephrology, Hospital Universitario San Cecilio, Granada, Spain
,
Enrique Raya-ÁlvarezDepartment of Rheumatology, Hospital Universitario San Cecilio, Granada, Spain
,
José Luis Rosales-AlexanderDepartment of Rheumatology, Hospital Universitario San Cecilio, Granada, Spain
,
Juan SalvatierraDepartment of Rheumatology, Hospital Universitario San Cecilio, Granada, Spain
,
Trinidad Caballero-MoralesDepartment of Pathology, Hospital Universitario San Cecilio, Granada, Spain
&
Mercedes Gómez-MoralesDepartment of Pathology, Hospital Universitario San Cecilio, Granada, Spain
 show all
Pages 235-239 | Received 14 Mar 2011, Accepted 13 May 2011, Published online: 12 Oct 2011

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Yasuaki Okuda. (2019) AA amyloidosis – Benefits and prospects of IL-6 inhibitors. Modern Rheumatology 29:2, pages 268-274.
Read now
Alice Courties, Gilles Grateau, Peggy Philippe, René-Marc Flipo, Leonardo Astudillo, Bérengère Aubry-Rozier, Isabelle Fabreguet, Wafki Fahd, Olivier Fain, Pascal Guggenbuhl, Eric Hachulla, Thomas Papo, Christophe Richez, Jean Sibilia, Jacques Morel, Francis Berenbaum & Jérémie Sellam. (2015) AA amyloidosis treated with tocilizumab: case series and updated literature review. Amyloid 22:2, pages 84-92.
Read now
Diego Real de Asúa, Ramón Costa, Jose María Galván, María Teresa Filigheddu, Davinia Trujillo & Julen Cadiñanos. (2014) Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clinical Epidemiology 6, pages 369-377.
Read now
M.D. Redondo-Pachón, R. Enríquez, A.E. Sirvent, E. Andrada, R. Noguera-Pons, I. Millán & F. Amorós. (2013) Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcet’s Disease. Renal Failure 35:4, pages 547-550.
Read now

Articles from other publishers (18)

Sandra M. Ihne-Schubert, Malte Kircher, Rudolf A. Werner, Constantin Lapa, Hermann Einsele, Andreas Geier & Torben Schubert. (2023) Vector autoregression: Useful in rare diseases?—Predicting organ response patterns in a rare case of secondary AA amyloidosis. PLOS ONE 18:8, pages e0289921.
Crossref
Jordan Thorne, David Clark, Laurette Geldenhuys, Keigan More, Amanda Vinson & Karthik Tennankore. (2022) Serum Amyloid A Protein–Associated Kidney Disease: Presentation, Diagnosis, and Management. Kidney Medicine 4:8, pages 100504.
Crossref
Florian Garo, Juliette Chatelain, Cedric Aglae & Olivier Moranne. (2021) Two cases of secondary AA amyloidosis involving the skin and chronic kidney infection with a nephrotic syndrome in a high-income country. BMJ Case Reports 14:6, pages e239411.
Crossref
D. Giannese, F. Ferro, D. Moriconi, A. G. Bonadio, E. Elefante, M. F. Egidi, A. Cupisti & C. Baldini. (2020) Use of tocilizumab in amyloid a nephropathy associated with Sweet syndrome: a case report and literature review. CEN Case Reports 10:1, pages 23-29.
Crossref
D. G. Rumyantseva, E. M. Agafonova, S. O. Krasnenko, A. S. Starkova, M. M. Urumova & Sh. Erdes. (2020) Clinical features of ankylosing spondylitis in patients with secondary AA amyloidosis. Modern Rheumatology Journal 14:3, pages 45-49.
Crossref
Shiang-Fen Huang, Ming-Han Chen, Fu-Der Wang, Chang-Youh Tsai, Chang-Phone Fung & Wei-Juin Su. (2018) Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders – A retrospective cohort study in Taiwan. Journal of Microbiology, Immunology and Infection 51:6, pages 784-793.
Crossref
E. Baux, S. Henard, C. Alauzet, F. Goehringer, C. Laurain, J. Champigneulle, P. Vaillant, A. Hardy, C. Rabaud & T. May. (2015) Amylose AA secondaire à une tuberculose pulmonaire multi-résistante : implications thérapeutiques. Revue de Pneumologie Clinique 71:5, pages 297-300.
Crossref
Tomoaki Murakami, Yasuo Inoshima & Naotaka Ishiguro. (2015) Systemic AA amyloidosis as a prion-like disorder. Virus Research 207, pages 76-81.
Crossref
S. A. Jones, D. J. Fraser, C. A. Fielding & G. W. Jones. (2014) Interleukin-6 in renal disease and therapy. Nephrology Dialysis Transplantation 30:4, pages 564-574.
Crossref
Julen Cadiñanos, Ramón Costa, Davinia Trujillo & Diego Real de Asúa. (2015) Amiloidosis sistémica secundaria AA. Medicina Clínica 144:7, pages 324-330.
Crossref
Julen Cadiñanos, Ramón Costa, Davinia Trujillo & Diego Real de Asúa. (2015) Systemic secondary AA amyloidosis. Medicina Clínica (English Edition) 144:7, pages 324-330.
Crossref
Kanata IBI, Tomoaki MURAKAMI, Wael Mohamed GODA, Naoki KOBAYASHI, Naotaka ISHIGURO & Tokuma YANAI. (2015) Prevalence of amyloid deposition in mature healthy chickens in the flock that previously had outbreaks of vaccine-associated amyloidosis. Journal of Veterinary Medical Science 77:10, pages 1241-1245.
Crossref
Shunsuke Yamada, Akihiro Tsuchimoto, Yoshiki Kaizu, Masatomo Taniguchi, Kosuke Masutani, Hiroshi Tsukamoto, Hiroaki Ooboshi, Kazuhiko Tsuruya & Takanari Kitazono. (2014) Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis. CEN Case Reports 3:2, pages 237-243.
Crossref
Graeme Jones & Changhai Ding. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 2023 2040 .
Masaru Matsui, Satoshi Okayama, Hideo Tsushima, Kenichi Samejima, Tomoko Kanki, Ayako Hasegawa, Katsuhiko Morimoto, Yasuhiro Akai, Masato Takano, Shiro Uemura, Chiho Ohbayashi & Yoshihiko Saito. (2014) Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis. Case Reports in Nephrology 2014, pages 1-6.
Crossref
A. Cañas-Ventura, E. Rodríguez, M. Andreu & L. Márquez. (2013) Tocilizumab in Amyloidosis-Associated Kidney Disease Secondary to Inflammatory Bowel Diseases. Digestive Diseases and Sciences 58:9, pages 2736-2737.
Crossref
Toshio Tanaka, Atsushi OgataMasashi Narazaki. (2013) Tocilizumab: An Updated Review of Its Use in the Treatment of Rheumatoid Arthritis and Its Application for Other Immune-Mediated Diseases. Clinical Medicine Insights: Therapeutics 5, pages CMT.S9282.
Crossref
Javier Rueda-Gotor, Miguel A González-Gay & Ricardo Blanco. (2012) Tocilizumab for the treatment of rheumatoid arthritis. Clinical Practice 9:3, pages 255-268.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.